APA (7th ed.) Citation

Genova, C., Marconi, S., Chiorino, G., Guana, F., Ostano, P., Santamaria, S., . . . Coco, S. (2024). Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab. Clinical and experimental medicine, 24(1), 182. https://doi.org/10.1007/s10238-024-01427-8

Chicago Style (17th ed.) Citation

Genova, Carlo, et al. "Extracellular Vesicles MiR-574-5p and MiR-181a-5p as Prognostic Markers in NSCLC Patients Treated with Nivolumab." Clinical and Experimental Medicine 24, no. 1 (2024): 182. https://doi.org/10.1007/s10238-024-01427-8.

MLA (9th ed.) Citation

Genova, Carlo, et al. "Extracellular Vesicles MiR-574-5p and MiR-181a-5p as Prognostic Markers in NSCLC Patients Treated with Nivolumab." Clinical and Experimental Medicine, vol. 24, no. 1, 2024, p. 182, https://doi.org/10.1007/s10238-024-01427-8.